Australia markets open in 7 hours 41 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
148.77-3.29 (-2.16%)
As of 12:17PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close152.06
Bid148.25 x 100
Ask148.96 x 100
Day's range147.31 - 150.62
52-week range110.45 - 211.13
Avg. volume451,309
Market cap8.313B
Beta (5Y monthly)1.03
PE ratio (TTM)551.00
EPS (TTM)0.27
Earnings date31 July 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est204.58

    Insider Sell: CEO Anthony Hunt Sells 20,072 Shares of Repligen Corp (RGEN)

    On May 21, 2024, Anthony Hunt, Chief Executive Officer of Repligen Corp (NASDAQ:RGEN), executed a sale of 20,072 shares of the company.

  • GlobeNewswire

    Repligen Corporation to Present at Upcoming June Investor Conferences

    WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June investor conferences. William Blair’s 44th Annual Growth Stock Conference being held in Chicago from June 4 – 6, 2024. Tony J. Hunt, Chief Executive Officer, is scheduled to present a company overview on June 5 at 12:00 p.m. CT.Jefferies’ Global Healthcare Conference being held

  • Insider Monkey

    Here’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)

    Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund (Institutional Shares) returned 4.57% underperforming the 7.58% return for the Russell 2000 Growth Index. The firm is optimistic about the Fund’s prospects for 2024. […]